Gemstone Spectral CT Virtual Noncontrast Images and Iodine Maps for the Characterization of Thyroid Lesions and Distinguishing Thyroid Papillary Carcinoma from Nodular Goiter.


Journal

International journal of endocrinology
ISSN: 1687-8337
Titre abrégé: Int J Endocrinol
Pays: Egypt
ID NLM: 101516376

Informations de publication

Date de publication:
2023
Historique:
received: 21 06 2022
revised: 07 12 2022
accepted: 30 01 2023
entrez: 9 3 2023
pubmed: 10 3 2023
medline: 10 3 2023
Statut: epublish

Résumé

Gemstone spectral contrast-enhanced CT with virtual noncontrast (VNC) images and iodine maps can potentially reduce the number of required CT scans for thyroid lesions. However, data regarding the clinical utility of VNC images and iodine maps in characterizing thyroid lesions and distinguishing thyroid papillary carcinoma from nodular goiter are still limited. To determine whether VNC images and iodine density could reliably aid in characterizing thyroid lesions and distinguishing thyroid papillary carcinoma from nodular goiter compared with true noncontrast (TNC) images. This retrospective study included patients with thyroid papillary carcinoma or nodular goiter who underwent TNC and contrast-enhanced gemstone spectral CT scans. The consistency of qualitative parameters, including intralesional calcification, necrosis, lesion boundary, thyroid edge interruption, and lymph node metastasis, between TNC and VNC images, was analyzed using the kappa statistic. TNC attenuation, VNC attenuation, absolute attenuation between TNC and VNC, and iodine density were compared between thyroid papillary carcinoma and nodular goiter by using Student's VNC and TNC imaging showed comparable performance in delineating calcification, necrosis, lesion boundary, thyroid edge interruption, and lymph node metastasis (all VNC imaging, a promising substitute for TNC imaging, has comparable diagnostic efficacy for reliably characterizing thyroid lesions. Iodine density could be valuable for distinguishing thyroid papillary carcinoma from nodular goiter.

Sections du résumé

Background UNASSIGNED
Gemstone spectral contrast-enhanced CT with virtual noncontrast (VNC) images and iodine maps can potentially reduce the number of required CT scans for thyroid lesions. However, data regarding the clinical utility of VNC images and iodine maps in characterizing thyroid lesions and distinguishing thyroid papillary carcinoma from nodular goiter are still limited.
Purpose UNASSIGNED
To determine whether VNC images and iodine density could reliably aid in characterizing thyroid lesions and distinguishing thyroid papillary carcinoma from nodular goiter compared with true noncontrast (TNC) images.
Methods UNASSIGNED
This retrospective study included patients with thyroid papillary carcinoma or nodular goiter who underwent TNC and contrast-enhanced gemstone spectral CT scans. The consistency of qualitative parameters, including intralesional calcification, necrosis, lesion boundary, thyroid edge interruption, and lymph node metastasis, between TNC and VNC images, was analyzed using the kappa statistic. TNC attenuation, VNC attenuation, absolute attenuation between TNC and VNC, and iodine density were compared between thyroid papillary carcinoma and nodular goiter by using Student's
Results UNASSIGNED
VNC and TNC imaging showed comparable performance in delineating calcification, necrosis, lesion boundary, thyroid edge interruption, and lymph node metastasis (all
Conclusions UNASSIGNED
VNC imaging, a promising substitute for TNC imaging, has comparable diagnostic efficacy for reliably characterizing thyroid lesions. Iodine density could be valuable for distinguishing thyroid papillary carcinoma from nodular goiter.

Identifiants

pubmed: 36891376
doi: 10.1155/2023/8220034
pmc: PMC9988381
doi:

Types de publication

Journal Article

Langues

eng

Pagination

8220034

Informations de copyright

Copyright © 2023 Chun Yao et al.

Déclaration de conflit d'intérêts

One author of the study (YT L) is a consultant for GE Healthcare; however, she was only responsible for the statistical analysis of features derived from patients' images. All features were anonymous, without the knowledge of patient information such as name, image data, and CT protocol acquisition. Our hospital managed the data, and the authors were responsible for the integrity of the data. The other authors are not employees or consultants in the industrial fields and have not controlled any data or information that may present a conflicts of interest.

Références

N Engl J Med. 2004 Oct 21;351(17):1764-71
pubmed: 15496625
Medicine (Baltimore). 2016 Sep;95(39):e4816
pubmed: 27684811
Eur J Radiol. 2016 Jul;85(7):1257-64
pubmed: 27235872
Clin Imaging. 2013 Jul-Aug;37(4):664-8
pubmed: 23462729
Eur J Radiol. 2021 Dec;145:110060
pubmed: 34839216
Asian Pac J Cancer Prev. 2015;16(6):2521-6
pubmed: 25824790
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32
pubmed: 26808342
BMC Cancer. 2021 Mar 4;21(1):221
pubmed: 33663422
Ultrasonography. 2015 Oct;34(4):304-11
pubmed: 26006056
Radiology. 2020 Aug;296(2):324-332
pubmed: 32452733
AJR Am J Roentgenol. 2020 Nov;215(5):1146-1154
pubmed: 32877251
J Xray Sci Technol. 2015;23(1):45-56
pubmed: 25567406
Med Phys. 2015 Jul;42(7):4349-66
pubmed: 26133632
Cancer Imaging. 2020 Apr 5;20(1):24
pubmed: 32248822
Radiol Clin North Am. 2021 Jul;59(4):525-533
pubmed: 34053603
Neuroradiology. 2016 Nov;58(11):1135-1141
pubmed: 27590748
Jpn J Radiol. 2021 Jun;39(6):580-588
pubmed: 33506433
J Am Coll Radiol. 2015 Feb;12(2):143-50
pubmed: 25456025
Radiology. 2019 May;291(2):381-390
pubmed: 30860450
J Clin Med. 2020 Aug 04;9(8):
pubmed: 32759779
Radiographics. 2011 Nov-Dec;31(7):1823-32
pubmed: 21969662
Neuroimaging Clin N Am. 2020 Aug;30(3):311-323
pubmed: 32600633
Int J Clin Exp Med. 2015 Apr 15;8(4):5800-5
pubmed: 26131168
Head Neck. 2019 Apr;41(4):1024-1031
pubmed: 30561806
Thyroid. 2013 Jul;23(7):885-91
pubmed: 23517343
Acta Radiol. 2020 Jan;61(1):21-27
pubmed: 31084186
Radiology. 2014 May;271(2):327-42
pubmed: 24761954
Int J Endocrinol. 2015;2015:908575
pubmed: 25954310
World J Clin Cases. 2016 Feb 16;4(2):38-48
pubmed: 26881190
BMC Med Imaging. 2019 Nov 21;19(1):92
pubmed: 31752728
J Thorac Imaging. 2012 Jan;27(1):7-22
pubmed: 22189245
Invest Radiol. 2012 Jan;47(1):58-64
pubmed: 21788907
Eur Radiol. 2017 Jul;27(7):2690-2697
pubmed: 27882426
Abdom Imaging. 2015 Apr;40(4):859-64
pubmed: 25270000
Oncol Lett. 2018 Jul;16(1):910-914
pubmed: 29963163
Abdom Radiol (NY). 2017 Mar;42(3):702-709
pubmed: 28084546
Abdom Radiol (NY). 2017 Jan;42(1):312-321
pubmed: 27470507

Auteurs

Chun Yao (C)

Department of Radiology, Meizhou People's Hospital, Meizhou 514031, China.

Xiaofeng Chen (X)

Department of Radiology, Meizhou People's Hospital, Meizhou 514031, China.
Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou 514031, China.

Zhiqi Yang (Z)

Department of Radiology, Meizhou People's Hospital, Meizhou 514031, China.
Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou 514031, China.

Ruibin Huang (R)

Department of Radiology, The First Affiliated Hospital of Shantou University Medical College, Shantou 515000, China.

Sheng Zhang (S)

Department of Radiology, Meizhou People's Hospital, Meizhou 514031, China.

Yuting Liao (Y)

GE Healthcare, Guangzhou 510623, China.

Xiangguang Chen (X)

Department of Radiology, Meizhou People's Hospital, Meizhou 514031, China.
Guangdong Provincial Key Laboratory of Precision Medicine and Clinical Translational Research of Hakka Population, Meizhou 514031, China.

Zhuozhi Dai (Z)

Department of Radiology, Shantou Central Hospital, Shantou, Guangdong 515031, China.
Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510120, China.

Classifications MeSH